Tools
Stock profile

TRUPANION, INC. (TRUP)

TRUP · Latest close $36.68 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$36.68
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
2
vs previous quarter

TRUPANION, INC. (TRUP) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $2.4M sold). Latest close $36.68 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 16, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-2.4M
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Greenlea Lane Capital — 1 tracked fund hold TRUP. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 13 sales ($2.4M). Insider trading

Often held alongside

Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · MOLINA HEALTHCARE, INC. (MOH) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Greenlea Lane Capital5.28%776,490HELD Q3 filed Nov 16
Maverick Capital——EXITED
Check Capital Management——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +39.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

56.4520.062024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding200 of 8,857 filers
Long-only filers among them199
Change vs 2026 Q1+6 net · 192 entered · 186 exited
Shares reported, all filers33,737,199
Reported value, all filers$828.1M

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryHospital & Medical Service Plans (SIC 6324)
Revenue · FY2025$1.4B
Net income · FY2025$19.4M
Total assets · FY2025$915.0M
Shares outstanding43,872,611
Market cap (at latest close)$1.6B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 29, 2026.

Short interest

Shares short · Oct 15, 20263,676,788
Share of shares outstanding8.38%
Days to cover9.31

Shares short at recent settlements — Jul 31, 2026: 3.7M · Aug 14, 2026: 4.0M · Aug 31, 2026: 4.0M · Sep 15, 2026: 4.1M · Sep 30, 2026: 3.9M · Oct 15, 2026: 3.7M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 29, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 91 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 29, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 13 sales by 5 insiders ($2.4M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 16, 2026RUBIN HOWARD ESell10,000$35.57$355.7KSEC filing
Nov 13, 2026RUBIN HOWARD ESell10,000$34.50$345.0KSEC filing
Nov 10, 2026LOW MURRAY BSell6,537$34.21$223.6KSEC filing
Nov 9, 2026Tooth MargaretCEOSell1,900$36.44$69.2KSEC filing
Nov 9, 2026Tooth MargaretCEOSell100$36.92$3.7KSEC filing
Nov 9, 2026RUBIN HOWARD ESell30,000$35.23$1.1MSEC filing
Oct 28, 2026GALLAGHER JOHN RChief Operating OfficerSell431$29.12$12.6KSEC filing
Oct 9, 2026Tooth MargaretCEOSell1,000$25.84$25.8KSEC filing
Sep 28, 2026GALLAGHER JOHN RChief Operating OfficerSell431$22.92$9.9KSEC filing
Sep 11, 2026Tooth MargaretCEOSell1,000$25.00$25.0KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Oct 9, 2026MARGARET R TOOTHOfficer, Director1,000$25.8KOct 9, 2026SEC filing
Sep 28, 2026JOHN GALLAGHEROfficer431$9.9KSep 28, 2026SEC filing
Sep 11, 2026MARGARET R TOOTHOfficer, Director1,000$25.0KSep 11, 2026SEC filing
Aug 28, 2026JOHN GALLAGHEROfficer3,604$107.0KAug 28, 2026SEC filing
Aug 26, 2026FAWWAD QURESHIOfficer6,111$183.4KAug 26, 2026SEC filing
Aug 11, 2026MARGARET R TOOTHOfficer, Director978$28.4KAug 11, 2026SEC filing
Jul 28, 2026JOHN GALLAGHEROfficer431$10.8KJul 28, 2026SEC filing
Jun 29, 2026JOHN GALLAGHEROfficer431$10.9KJun 29, 2026SEC filing
Jun 5, 2026STEVE A WEINRAUCHOfficer6,674$146.8KJun 5, 2026SEC filing
May 28, 2026JOHN GALLAGHEROfficer3,603$78.2KMay 28, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 25, 2026Tarmac DLTFM LtdSC 13G/A00.0%Feb 17, 2026SEC filing
Feb 24, 2026FELIX HOLDINGS BVSC 13G4,296,5389.9%Feb 17, 2026SEC filing
Oct 10, 2025Tarmac DLTFM LtdSC 13G/A3,575,5388.3%Oct 11, 2023SEC filing
Aug 12, 2025Wellington Management Group LLPSC 13G/A2,038,4584.8%Jun 30, 2025SEC filing
Feb 10, 2025Wellington Management Group LLPSC 13G/A2,200,5375.2%Dec 31, 2024SEC filing
Feb 4, 2025FLOSSBACH VON STORCH SESC 13G00.0%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Hospital & Medical Service Plans (SIC 6324). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Growth — Latest revenue: $1.4B · 5-yr revenue CAGR: 23.4% · Straight growth years: 13

· Cash Flow (FCF) — Latest FCF: $75.4M · FCF yield: 5.7% · Positive FCF years: 3

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together1100.0%+38.1%+12.1%+26.0%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold TRUP — ranked by lift, the co-holding pattern described in Methodology: Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · MOLINA HEALTHCARE, INC. (MOH) · Oscar Health, Inc. (OSCR) · PROGRESSIVE CORP/OH/ (PGR) · Chubb Ltd (CB).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 5, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 5, 20262.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Jun 15, 20265.07 Submission of Matters to a Vote of Security HoldersSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Elevance Health, Inc. (ELV) · Track Record: how the signals scored · Practice timing on TRUP

One email a week: the week’s new filings and research. Subscribe free

← TRU  ·  TRV →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.